Antigenic characterization of the inclusion body hepatitis virus
- PMID: 804835
Antigenic characterization of the inclusion body hepatitis virus
Abstract
Proof that inclusion body hepatitis of chickens (IBHC) is caused by a virus (IBHV) was established in 1973. Characterization of IBHV has been conducted by employing the standard criteria for virus classification. The results have indicated that IBHV is a member of the avian adenovirus group. However, no antigenic relationship was found between IBHV and two other avian adenovirus isolates (CELO and Indiana C) as observed by hemagglutination (HA) and virus-serum neutralization tests. Another adenovirus isolate was found to be serologically different from IBHV (Tipton strain) but it incited typical IBHC in susceptible chicks. A novel antigen, detectable by the agar gel immunodiffusion test, was demonstrated in livers from chicks infected experimentally with IBHV. This antigen was able to give a specific precipitin reaction with serums from chickens previously exposed to IBHV. Repeated embryo passage of IBHV lowered its pathogenicity for susceptible chickens. Protection of chickens against IBHV challenge was obtained by vaccination with high embryo passage IBHV (Tipton strain). It was also found that subcutaneous administration of the vaccine virus induced a better immune response than the eye-drop route as observed by the virus-serum neutralization index obtained.
Similar articles
-
Serologic and pathogenicity studies of avian adenovirus isolated from chickens with inclusion body hepatitis.Avian Dis. 1978 Jan-Mar;22(1):177-80. Avian Dis. 1978. PMID: 206251
-
Some properties of avian adenoviruses isolated from chickens with inclusion body hepatitis in Japan.Avian Dis. 1976 Oct-Dec;20(4):693-705. Avian Dis. 1976. PMID: 186009
-
Administration of Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and Avian Beta Defensin as Adjuvants in Inactivated Inclusion Body Hepatitis Virus and its Hexon Protein-Based Experimental Vaccine Formulations in Chickens.Avian Dis. 2015 Dec;59(4):518-24. doi: 10.1637/11202-052815-Reg.1. Avian Dis. 2015. PMID: 26629626 Clinical Trial.
-
Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.Vaccine. 2004 Jun 2;22(17-18):2351-60. doi: 10.1016/j.vaccine.2003.10.039. Vaccine. 2004. PMID: 15149796
-
Adenoviral antigens (CELO, QBV, GAL).Am J Vet Res. 1975 Apr;36(4 Pt 2):527-9. Am J Vet Res. 1975. PMID: 804833 Review. No abstract available.
Cited by
-
Preparation and evaluation of chicken embryo-adapted fowl adenovirus serotype 4 vaccine in broiler chickens.Trop Anim Health Prod. 2011 Feb;43(2):331-8. doi: 10.1007/s11250-010-9694-z. Epub 2010 Sep 28. Trop Anim Health Prod. 2011. PMID: 20878234
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources